ty-9591

Small moleculeexperimental

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06672068Phase 2Dec 1, 2024TYK Medicines, Inc
NCT05948813Phase 2Aug 17, 2023Chinese Academy of Medical Sciences, TYK Medicines, Inc
NCT05871905Phase 1Jun 25, 2023Suzhou First People's Hospital, TYK Medicines, Inc
NCT05382728Phase 3Jun 8, 2022Central South University, Jiao Tong University, TYK Medicines, Inc
NCT05146219Phase 2Dec 31, 2021Chinese Academy of Medical Sciences, TYK Medicines, Inc
NCT04798638Phase 1May 1, 2021Hunan Provincal Tumor Hospital, TYK Medicines, Inc
NCT04204473Phase 1Jan 15, 2020TYK Medicines, Inc
Showing 7 of 7 trials
Page 1 / 1

Organizations

Research & Development (6)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
TYK Medicines, IncFor profit7732020
Chinese Academy of Medical SciencesAcademic/Hospital2012021
Central South UniversityAcademic/Hospital1012022
Hunan Provincal Tumor HospitalAcademic/Hospital1012021
Jiao Tong UniversityAcademic/Hospital1012022
Suzhou First People's HospitalAcademic/Hospital1012023
6 organizations
Page 1 / 1